215 related articles for article (PubMed ID: 33480702)
1. Improved Cellular Delivery of Antisense Oligonucleotide for miRNA-21 Imaging In Vivo Using Cell-Penetrating Peptide-Based Nanoprobes.
Yang G; Zhao Y; Gong A; Miao W; Yan L; Nie P; Wang Z
Mol Pharm; 2021 Mar; 18(3):787-795. PubMed ID: 33480702
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive visualization of microRNA-155 in multiple kinds of tumors using a radiolabeled anti-miRNA oligonucleotide.
Kang L; Huo Y; Ji Q; Fan S; Yan P; Zhang C; Ma H; Hao P; Sun H; Zheng Z; Xu X; Wang R
Nucl Med Biol; 2016 Feb; 43(2):171-8. PubMed ID: 26872442
[TBL] [Abstract][Full Text] [Related]
3. Improved synthesis and biological evaluation of Tc-99m radiolabeled AMO for miRNA imaging in tumor xenografts.
Kang L; Fan Z; Sun H; Feng Y; Ma C; Yan P; Zhang C; Ma H; Hao P; Chen X; Zheng Z; Xu X; Wang R
J Labelled Comp Radiopharm; 2015; 58(13-14):461-8. PubMed ID: 26503645
[TBL] [Abstract][Full Text] [Related]
4. [In vivo imaging of breast tumors by a
Kang L; Huo Y; Wang RF; Zhang CL; Yan P; Xu XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):326-330. PubMed ID: 29643534
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
Fu P; Shen B; Zhao C; Tian G
J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
[TBL] [Abstract][Full Text] [Related]
6. Radiosynthesis of a novel antisense imaging probe targeting LncRNA HOTAIR in malignant glioma.
Ren J; Zhang X; Cao J; Tian J; Luo J; Yu Y; Wang F; Zhao Q
BMC Cancer; 2022 Jan; 22(1):79. PubMed ID: 35042456
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
8. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
[TBL] [Abstract][Full Text] [Related]
9. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
12. [Transfection of hypertrophic cardiac myocytes in vitro with (99)Tc(m)-labeled antisense miR208b oligonucleotide].
Wang J; Feng H; Ou Y; Sun Y; Wu J; Chen P
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1316-9. PubMed ID: 26403746
[TBL] [Abstract][Full Text] [Related]
13. SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL.
Li F; Zhang Z; Cheng T; Wei R; Dai Y; Lv M; Luo D; Zhu X; Ma D; Xi L; Dong Q; Ma X
Amino Acids; 2016 Jan; 48(1):91-101. PubMed ID: 26255282
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.
Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z
Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409
[TBL] [Abstract][Full Text] [Related]
15. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
16. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
17. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and SPECT imaging study of (99m)Tc labeling NGR peptide in nude mice bearing human HepG2 hepatoma.
Ma W; Wang Z; Yang W; Ma X; Kang F; Wang J
Biomed Res Int; 2014; 2014():618096. PubMed ID: 24977153
[TBL] [Abstract][Full Text] [Related]
19. Anti-sense oligonucleotide labeled with technetium-99m using hydrazinonictinamide derivative and N-hydroxysuccinimidyl S-acetylmercaptoacetyltriglycline: a comparison of radiochemical behaviors and biological properties.
Li YC; Tan TZ; Zheng JG; Zhang C
World J Gastroenterol; 2008 Apr; 14(14):2235-40. PubMed ID: 18407601
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging and pharmacokinetics of (99m) Tc-hTERT antisense oligonucleotide as a potential tumor imaging probe.
Liu M; Wang RF; Yan P; Zhang CL; Cui YG
J Labelled Comp Radiopharm; 2014 Feb; 57(2):97-101. PubMed ID: 24307558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
